Sentences with phrase «on immunotherapeutic»

Not exact matches

Sources tell 2 On Your Side's Michael Wooten that the Office of Congressional Ethics probe is examining Collins» purchase of stock in a biotech company called Innate Immunotherapeutics, and the investigation is «moving swiftly».

Democrats also criticized Price and Collins for trading these types of health care stocks just before voting to pass the 21st Century Cures Act, which reportedly made it easier for companies like Innate Immunotherapeutics to seek FDA approval for trials on experimental treatments.

Collins, who has denied any wrongdoing, was the largest shareholder of Australia's Innate Immunotherapeutics Limited and sat on the company's board of directors.

Government ethics experts and a senior New York Democrat question whether Rep. Chris Collins — by far the largest shareholder in an Australian - based biotech company called Innate Immunotherapeutics — and Georgia Rep. Tom Price, Trump's health secretary nominee, bought stock in the company last year based on inside information and made a lot of moneys a result.

The ethics office — an independent, nonpartisan entity charged with reviewing allegations of misconduct against members, officers and staff — is concentrating on his investments in Innate Immunotherapeutics.

Collins backers are taking heart in the fact that nowhere in the 29 - page Office of Congressional Ethics report is there any claim or any evidence that he wrote legislation on behalf of Innate Immunotherapeutics — the most explosive charge leveled against him by Rep. Louise Slaughter.

Despite an ethics probe into his efforts on behalf of Innate Immunotherapeutics an Australian biotech firm, which is expected to culminate in a report in the coming week, Rep. Chris Collins has stepped up his outside business interests.

Rep. Chris Collins (R - NY), seen in a 2016 file photo, is on the board of directors of Innate Immunotherapeutics, an Australian firm whose stock fell sharply this week.

Collins is the largest shareholder in that company, Innate Immunotherapeutics, which is working on an experimental treatment for secondary progressive multiple sclerosis.

«The bioinspired T cell - activating scaffolds developed by the Wyss Institute's Immunomaterials Platform could accelerate the success of many immunotherapeutic approaches in the clinic, with life - saving impact on a broad range of patients, in addition to advancing personalized medicine,» said Wyss Institute Founding Director Donald Ingber, M.D., Ph.D., who is also the Judah Folkman Professor of Vascular Biology at HMS and the Vascular Biology Program at Boston Children's Hospital, as well as Professor of Bioengineering at SEAS.

In 2011, he established the Immunotherapeutics Clinical Core, a specialized phase 1 outpatient unit at MSK that is focused on the conduct of novel immunotherapy trials, with a specific emphasis on pharmacodynamic biomarker identification.

One of the immunotherapeutic approaches that has been explored thus far relies on the use of monoclonal antibodies that specifically target a protein present on the surface of prostate cancer cells called prostate specific membrane antigen (PSMA) to elicit an anti-tumor immune response and control the cancer.

A study led by scientists at The Wistar Institute describes a novel immunotherapeutic strategy for the treatment of cancer based on the use of synthetic DNA to directly encode protective antibodies against a cancer specific protein.

Our findings show how the tumor microenvironment drives the acquisition of CD39 as an immune regulatory molecule on CD8 + T cells, with implications for defining a biomarker of T cell dysfunction and a target for immunotherapeutic intervention.

Nonetheless, the first cellular immunotherapeutic product on the market has generated $ 228M revenue in 2011.

hen tiny Australian biotech firm Innate Immunotherapeutics needed to raise money last summer, it didn't issue stock on the open market.

Young Kim, M.D., Ph.D., Associate Professor of Otolaryngology and co-leader of the Translational Research and Interventional Oncology Research Program, is a clinician - scientist focused on the development of immunotherapeutic modalities for solid tumors.

Immunotherapeutic concepts to target acute myeloid leukemia: focusing on the role of monoclonal antibodies, hypomethylating agents and the leukemic microenvironment

[2] Michael Schwalb, Margit Taubmann, Steve Hines, Heinz Reinwald and Marco Ruggiero; Clinical Observation of a Novel, Complementary, Immunotherapeutic Approach based on Ketogenic Diet, Chondroitin Sulfate, Vitamin D3, Oleic Acid and a Fermented Milk and Colostrum Product,» American Journal of Immunology, Case Reports, 12/21/2016, Volume 12, Issue 4.

NewLink Genetics Corporation is a biopharmaceutical company focused on discovering, developing and commercializing novel immunotherapeutic products to improve cancer treatment options for patients and physicians.